SCHD vs VIG: returns, risk and drawdowns compared
Schwab U.S. Dividend Equity ETF against Vanguard Dividend Appreciation ETF, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
SCHD
Schwab U.S. Dividend Equity ETF
10,000 became
23,140
- A year on average
- +14.2%
- Annual volatility
- 15.7%
- Deepest fall
- −17.1%
- Worst month
- −8.6%
VIG
Vanguard Dividend Appreciation ETF
10,000 became
23,043
- A year on average
- +14.1%
- Annual volatility
- 13.6%
- Deepest fall
- −20.2%
- Worst month
- −8.2%
SCHD came out ahead by 0.1 percentage points a year from July 2020 to October 2026. SCHD swung more (15.7% against 13.6% a year). The correlation of monthly returns was 0.84: they usually moved together.
Growth of 10,000: SCHD vs VIG
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero SCHD had returned more, below zero VIG. SCHD was ahead in 10% of the 41 three-year periods.
Annualised 3-year return of SCHD minus that of VIG, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: SCHD −17.1%, VIG −20.2%.
All the figures
| SCHD | VIG | |
|---|---|---|
| Annual return (CAGR) | +14.2% | +14.1% |
| Total return | +131% | +130% |
| Annual volatility | 15.7% | 13.6% |
| Deepest fall (month-end) | −17.1% | −20.2% |
| Worst month | −8.6% | −8.2% |
| Best month | +13.2% | +10.0% |
| Positive months | 59% | 64% |
| Best year | 2021: +27.3% | 2021: +23.8% |
| Worst year | 2022: −5.5% | 2022: −9.8% |
| 1-year return | +37.2% | +13.5% |
| 5 years, a year | +8.5% | +10.3% |
| 10 years, a year | +11.5% | — |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half SCHD, half VIG
| SCHD alone | VIG alone | 50/50 | |
|---|---|---|---|
| A year on average | +14.2% | +14.1% | +14.2% |
| Annual volatility | 15.7% | 13.6% | 14.1% |
| Deepest fall (month-end) | −17.1% | −20.2% | −18.6% |
| Worst month | −8.6% | −8.2% | −8.1% |
Because the two did not always move together, the mix swung less than the average of the two (14.1% against 14.6%). Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, SCHD or VIG?
From July 2020 to October 2026, SCHD returned +14.2% a year and VIG +14.1% a year, with dividends reinvested. Over rolling 3-year periods SCHD did better in 10% of cases. Past returns do not predict future returns.
Which is riskier, SCHD or VIG?
Over the same months annual volatility was 15.7% for SCHD and 13.6% for VIG; the deepest fall from a month-end high was 17.1% and 20.2%, and the worst single month −8.6% and −8.2%.
How correlated are SCHD and VIG?
The correlation of their monthly returns was 0.84: they usually moved together. Combining them has historically given some diversification.
What about holding both SCHD and VIG?
Half in each, rebalanced every month, returned +14.2% a year over the same period, with 14.1% annual volatility and a deepest month-end fall of 18.6%.
More comparisons
- SCHD — Schwab U.S. Dividend Equity ETFReturns, drawdowns and risk
- VIG — Vanguard Dividend Appreciation ETFReturns, drawdowns and risk
- SCHD vs VYM
- SCHD vs DGRO
- VOO vs SCHD
- SCHD vs JEPI
- VYM vs VIG
- VIG vs DGRO
- Backtest a portfolio with rebalancing and costsRebalancing, costs and attribution
- Portfolio Visualizer alternativesWhich tool fits which job
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.